439 related articles for article (PubMed ID: 24287560)
1. Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
Ottanà R; Maccari R; Mortier J; Caselli A; Amuso S; Camici G; Rotondo A; Wolber G; Paoli P
Eur J Med Chem; 2014 Jan; 71():112-27. PubMed ID: 24287560
[TBL] [Abstract][Full Text] [Related]
2. New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells.
Ottanà R; Maccari R; Amuso S; Wolber G; Schuster D; Herdlinger S; Manao G; Camici G; Paoli P
Eur J Med Chem; 2012 Apr; 50():332-43. PubMed ID: 22381357
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents.
Ottanà R; Paoli P; Naß A; Lori G; Cardile V; Adornato I; Rotondo A; Graziano ACE; Wolber G; Maccari R
Eur J Med Chem; 2017 Feb; 127():840-858. PubMed ID: 27842892
[TBL] [Abstract][Full Text] [Related]
4. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors.
Ottanà R; Maccari R; Ciurleo R; Paoli P; Jacomelli M; Manao G; Camici G; Laggner C; Langer T
Bioorg Med Chem; 2009 Mar; 17(5):1928-37. PubMed ID: 19217304
[TBL] [Abstract][Full Text] [Related]
5. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
[TBL] [Abstract][Full Text] [Related]
7. 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases.
Maccari R; Paoli P; Ottanà R; Jacomelli M; Ciurleo R; Manao G; Steindl T; Langer T; Vigorita MG; Camici G
Bioorg Med Chem; 2007 Aug; 15(15):5137-49. PubMed ID: 17543532
[TBL] [Abstract][Full Text] [Related]
8. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives.
Li Y; Lu L; Zhu M; Wang Q; Yuan C; Xing S; Fu X; Mei Y
Biometals; 2011 Dec; 24(6):993-1004. PubMed ID: 21618062
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.
Han H; Lu L; Wang Q; Zhu M; Yuan C; Xing S; Fu X
Dalton Trans; 2012 Aug; 41(36):11116-24. PubMed ID: 22864521
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying the inhibitory effects of arsenic compounds on protein tyrosine phosphatase (PTP).
Rehman K; Chen Z; Wang WW; Wang YW; Sakamoto A; Zhang YF; Naranmandura H; Suzuki N
Toxicol Appl Pharmacol; 2012 Sep; 263(3):273-80. PubMed ID: 22771847
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
Liu P; Du Y; Song L; Shen J; Li Q
Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
[TBL] [Abstract][Full Text] [Related]
13. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
[TBL] [Abstract][Full Text] [Related]
14. Dinuclear copper complexes of organic claw: potent inhibition of protein tyrosine phosphatases.
Ma L; Lu L; Zhu M; Wang Q; Gao F; Yuan C; Wu Y; Xing S; Fu X; Mei Y; Gao X
J Inorg Biochem; 2011 Sep; 105(9):1138-47. PubMed ID: 21708098
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of several protein tyrosine phosphatases in diabetes].
Chen M; Sun JP; Liu J; Yu X
Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
[TBL] [Abstract][Full Text] [Related]
16. Effects of small interference RNA against PTP1B and TCPTP on insulin signaling pathway in mouse liver: evidence for non-synergetic cooperation.
Xu J; Li L; Hong J; Huang W
Cell Biol Int; 2007 Jan; 31(1):88-91. PubMed ID: 17088077
[TBL] [Abstract][Full Text] [Related]
17. Click to a focused library of benzyl 6-triazolo(hydroxy)benzoic glucosides: novel construction of PTP1B inhibitors on a sugar scaffold.
Li C; He XP; Zhang YJ; Li Z; Gao LX; Shi XX; Xie J; Li J; Chen GR; Tang Y
Eur J Med Chem; 2011 Sep; 46(9):4212-8. PubMed ID: 21745700
[TBL] [Abstract][Full Text] [Related]
18. C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts.
Li ZG; Qiang X; Sima AA; Grunberger G
Biochem Biophys Res Commun; 2001 Jan; 280(3):615-9. PubMed ID: 11162564
[TBL] [Abstract][Full Text] [Related]
19. A focused library of protein tyrosine phosphatase inhibitors.
Comeau AB; Critton DA; Page R; Seto CT
J Med Chem; 2010 Sep; 53(18):6768-72. PubMed ID: 20731359
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of cold and hot tea extracts on tyrosine phosphatases regulating insulin receptor activity: a focus on PTP1B and LMW-PTP.
Genovese M; Luti S; Pardella E; Vivoli-Vega M; Pazzagli L; Parri M; Caselli A; Cirri P; Paoli P
Eur J Nutr; 2022 Jun; 61(4):1905-1918. PubMed ID: 35066640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
